Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01400594 · ClinicalTrials.gov registry record · Phase 2
Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail
A Phase 2 study, sponsored by Hisamitsu Pharmaceutical Co..
- Completed
- Registry status
- Phase 2
- Development phase
- 182
- Enrollment target
NCT01400594: Completed Phase 2 study, sponsored by Hisamitsu Pharmaceutical Co..
NCT01400594 is a Phase 2 study that has completed, run by Hisamitsu Pharmaceutical Co.. The registered enrollment target is 182 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (37% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01400594, a Phase 2 study, has completed, sponsored by Hisamitsu Pharmaceutical Co..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 182 participants
- Enrollment target
Study Summary
This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of HTU-520 in subjects with clinically diagnosed onychomycosis of the great toenail.
Interventions
- OTHER Placebo Patch
- DRUG HTU-520 Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2011-07 |
| Est. Completion | 2013-01 |
| Phase | Phase 2 |
What the finished NCT01400594 record still lists
NCT01400594 is an interventional study that assigns participants to a tested intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (37% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo Patch is the first listed.
NCT01400594 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01400594 about?
NCT01400594 is a clinical study titled "Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail". This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of HTU-520 in subjects with clinically diagnosed onychomycosis of the great toenail.
What is the current status of trial NCT01400594?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 182 participants. The study started on 2011-07. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01400594?
The interventions under investigation include: Placebo Patch (OTHER), HTU-520 Patch (DRUG).
Who is sponsoring clinical trial NCT01400594?
This trial is sponsored by Hisamitsu Pharmaceutical Co., which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01400594's enrollment target sits among peer trials
182 363rd of 2000 higher than 1,636 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT05606731 · 182 participants · NA
Family Intervention to Prevent Childhood Obesity
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia